PKA-dependent phosphorylation of PSMG1 reduces bortezomib sensitivity in hepatocellular carcinoma.
- DOI
- 10.1016/j.drup.2026.101495
- Published
- 2026 Oct 29
- Container
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drup.2026.101495,
title = {PKA-dependent phosphorylation of PSMG1 reduces bortezomib sensitivity in hepatocellular carcinoma.},
author = {Liu WJ and Zeng SJ and Cai SW and Zhu YQ and Huang YP and Niu WY and Song XP and Lan ZH and Wang MJ and Bao HS and Shi Z},
year = {2026},
journal = {Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy},
doi = {10.1016/j.drup.2026.101495},
url = {https://doi.org/10.1016/j.drup.2026.101495}
}RIS
TY - JOUR TI - PKA-dependent phosphorylation of PSMG1 reduces bortezomib sensitivity in hepatocellular carcinoma. AU - Liu WJ AU - Zeng SJ AU - Cai SW AU - Zhu YQ AU - Huang YP AU - Niu WY AU - Song XP AU - Lan ZH AU - Wang MJ AU - Bao HS AU - Shi Z PY - 2026 JO - Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy DO - 10.1016/j.drup.2026.101495 UR - https://doi.org/10.1016/j.drup.2026.101495 ER -
APA
WJ, L., SJ, Z., SW, C., YQ, Z., YP, H., WY, N., XP, S., ZH, L., MJ, W., HS, B., & Z, S. (2026). PKA-dependent phosphorylation of PSMG1 reduces bortezomib sensitivity in hepatocellular carcinoma.. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. https://doi.org/10.1016/j.drup.2026.101495
Source records
- pubmed · retrieved 2026-11-10T09:28:42.344Z